Zobrazeno 1 - 10
of 47
pro vyhledávání: '"Antonio Rueda Domínguez"'
Autor:
Juana María Sepúlveda-Sánchez, Francisco Rivas-Ruiz, Antonio Rueda Domínguez, Silvia Aguilar Carmona, Concepción Ruiz Hernández, José Carlos Canca-Sánchez
Publikováno v:
Psicooncologia, Vol 16, Iss 2, Pp 345-356 (2019)
Objetivo: Diseño y validación de un instrumento de medida de la satisfacción manifestada por pacientes en tratamiento oncológico en régimen ambulatorio en Hospital de Día. Método: Estudio transversal descriptivo de periodo mediante la administ
Externí odkaz:
https://doaj.org/article/5eddacb724eb4f53bfcc193c0803407b
Autor:
Vanesa Gutiérrez Calderón, Alexandra Cantero González, Laura Gálvez Carvajal, Yolanda Aguilar Lizarralde, Antonio Rueda Domínguez
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 13 (2021)
Squamous cell carcinoma of oral cavity (OCSCC) accounts for approximately 25% of cases of head and neck squamous cell carcinoma (HNSCC). Tobacco and alcohol consumption are the main risk factors for both cancers. Surgical resection, combined with adj
Externí odkaz:
https://doaj.org/article/3c485da470d34a59bf1d986d216bfb08
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 43, Iss 1, Pp 1-29 (2024)
Abstract Hodgkin lymphoma (HL) represents a neoplasm primarily affecting adolescents and young adults, necessitating the development of precise diagnostic and monitoring tools. Specifically, classical Hodgkin lymphoma (cHL), comprising 90% of cases,
Externí odkaz:
https://doaj.org/article/5e06a2cf86ad429cb092962d41c6020e
Autor:
Antonio J Castro Gómez, Armando López-Guillermo, Antonio Rueda Domínguez, Antonio Salar, Cristina Varela Moreno, Carlos Rubio-Terrés
Publikováno v:
Revista Española de Salud Pública, Vol 86, Iss 2, Pp 163-176 (2012)
Fundamentos: El tratamiento de mantenimiento con rituximab del linfoma folicular (LF) que responde a la inducción en primera línea, aumenta de manera significativa la supervivencia libre de progresión en comparación con la observación. Para eval
Externí odkaz:
https://doaj.org/article/e28e52b0dbda439e8c110d6f4f34f31b
Autor:
Lourdes Hontecillas-Prieto, Daniel J. García-Domínguez, Natalia Palazón-Carrión, Alejandro Martín García-Sancho, Esteban Nogales-Fernández, Carlos Jiménez-Cortegana, María L. Sánchez-León, Silvia Silva-Romeiro, Rocío Flores-Campos, Fernando Carnicero-González, Eduardo Ríos-Herranz, Fátima de la Cruz-Vicente, Guillermo Rodríguez-García, Rubén Fernández-Álvarez, Natividad Martínez-Banaclocha, Josep Gumà-Padrò, José Gómez-Codina, Antonio Salar-Silvestre, Delvys Rodríguez-Abreu, Laura Gálvez-Carvajal, Jorge Labrador, María Guirado-Risueño, Mariano Provencio-Pulla, Margarita Sánchez-Beato, Lejeune Marylene, Tomás Álvaro-Naranjo, María Casanova-Espinosa, Antonio Rueda-Domínguez, Víctor Sánchez-Margalet, Luis de la Cruz-Merino
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
BackgroundDiffuse large B cell lymphoma (DLBCL) is the most common non-Hodgkin lymphoma worldwide. DLBCL is an aggressive disease that can be cured with upfront standard chemoimmunotherapy schedules. However, in approximately 35-40% of the patients D
Externí odkaz:
https://doaj.org/article/212d6baeaf2d4c8bb7bf0ab05ba40793
Autor:
Quadri Ajibola Omotesho, Alejandro Escamilla, Elisabeth Pérez-Ruiz, Cecilia A. Frecha, Antonio Rueda-Domínguez, Isabel Barragán
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
Tertiary lymphoid structures (TLS) are ectopic lymphoid aggregates found in sites of chronic inflammation such as tumors and autoimmune diseases. The discovery that TLS formation at tumor sites correlated with good patient prognosis has triggered ext
Externí odkaz:
https://doaj.org/article/f565f72fda4649d2b60b4bca4dc6b660
Autor:
Juan Zafra, Juan Luis Onieva, Javier Oliver, María Garrido-Barros, Andrea González-Hernández, Beatriz Martínez-Gálvez, Alicia Román, Rafael Ordóñez-Marmolejo, Elisabeth Pérez-Ruiz, José Carlos Benítez, Andrés Mesas, Andrés Vera, Rodolfo Chicas-Sett, Antonio Rueda-Domínguez, Isabel Barragán
Publikováno v:
International Journal of Molecular Sciences, Vol 25, Iss 8, p 4533 (2024)
Up to 80% of patients under immune checkpoint inhibitors (ICI) face resistance. In this context, stereotactic ablative radiotherapy (SABR) can induce an immune or abscopal response. However, its molecular determinants remain unknown. We present early
Externí odkaz:
https://doaj.org/article/db5ba8ef1f93461aabaa8b19946c07b0
Autor:
Janet Delgado Rodríguez, Vanesa Ramos‐García, Diego Infante‐Ventura, José Carlos Suarez‐Herrera, Antonio Rueda‐Domínguez, Pedro Serrano‐Aguilar, María del Mar Trujillo‐Martín
Publikováno v:
Health Expectations. 26:567-578
Scalp cooling (SC) aims to prevent chemotherapy-induced alopecia. The goal of this systematic review is to tackle ethical, legal, organizational and social issues related to SC.A critical appraisal of the literature was carried out using a systematic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::55a0088868bad23704989f183d7548f4
https://doi.org/10.1111/hex.13679
https://doi.org/10.1111/hex.13679
Autor:
Tasmania del Pino-Sedeño, Diego Infante-Ventura, Aythami de Armas Castellano, Pedro de Pablos-Rodríguez, Antonio Rueda-Domínguez, Pedro Serrano-Aguilar, María M. Trujillo-Martín
Publikováno v:
European Urology Open Science. 46:105-127
Prostate cancer (PCa) is the second most common type of cancer in men. Individualized risk stratification is crucial to adjust decision-making. A variety of molecular biomarkers have been developed in order to identify patients at risk of clinically
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cace17fa277db56382ab6710dab48f91
https://doi.org/10.1016/j.euros.2022.10.017
https://doi.org/10.1016/j.euros.2022.10.017
Autor:
Barragán, Javier Oliver, Juan Luis Onieva, María Garrido-Barros, Manuel Cobo-Dols, Beatriz Martínez-Gálvez, Ana Isabel García-Pelícano, Jaime Dubbelman, José Carlos Benítez, Juan Zafra Martín, Alejandra Cantero, Elisabeth Pérez-Ruiz, Antonio Rueda-Domínguez, Isabel
Publikováno v:
Cancers; Volume 15; Issue 13; Pages: 3357
The present study aimed to investigate the potential of basal cell-free fluorometric DNA (cfDNA) quantification as a prognostic biomarker in advanced non-small cell lung cancer (NSCLC) patients treated with an Immune Checkpoint Blockade (ICB). A disc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=multidiscipl::8e016e3769ae09aec24fece63c55a8b1